Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoltan Pataky

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Physiological Reports|March 26, 2021
Sphingosine-1-phosphate as a key player of insulin secretion induced by high-density lipoprotein treatmentMarie-Claude Brulhart-Meynet, Aurélien Thomas, Jonathan Sidibé, et al.
Diabetologia|May 29, 2019
Cellular circadian period length inversely correlates with HbA<sub>1c</sub> levels in individuals with type 2 diabetesFlore Sinturel, Anne-Marie Makhlouf, Patrick Meyer, et al.
JACC. Cardiovascular Imaging|August 18, 2012
Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammationAlessandra Quercioli, Zoltan Pataky, Fabrizio Montecucco, et al.
Thrombosis and Haemostasis|November 22, 2014
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathwaysFabrizio Montecucco, Sébastien Lenglet, Alessandra Quercioli, et al.
BMJ Open|October 29, 2025
Use of digital self-care solutions for diabetes long-term management: a scoping review protocolJorge César Correia, Cosette Fakih El Khoury, Dayana El Chaar, et al.
European Heart Journal|February 10, 2011
Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesityAlessandra Quercioli, Zoltan Pataky, Gabriella Vincenti, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 12, 2016
Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell ProtectionJonas W Brinck, Aurélien Thomas, Estelle Lauer, et al.
Acta Physiologica (Oxford, England)|December 22, 2020
Ether lipids, sphingolipids and toxic 1-deoxyceramides as hallmarks for lean and obese type 2 diabetic patientsJ Thomas Hannich, Ursula Loizides-Mangold, Flore Sinturel, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Physiological Reports|March 26, 2021
Sphingosine-1-phosphate as a key player of insulin secretion induced by high-density lipoprotein treatmentMarie-Claude Brulhart-Meynet, Aurélien Thomas, Jonathan Sidibé, et al.
Diabetologia|May 29, 2019
Cellular circadian period length inversely correlates with HbA<sub>1c</sub> levels in individuals with type 2 diabetesFlore Sinturel, Anne-Marie Makhlouf, Patrick Meyer, et al.
JACC. Cardiovascular Imaging|August 18, 2012
Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammationAlessandra Quercioli, Zoltan Pataky, Fabrizio Montecucco, et al.
Thrombosis and Haemostasis|November 22, 2014
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathwaysFabrizio Montecucco, Sébastien Lenglet, Alessandra Quercioli, et al.
BMJ Open|October 29, 2025
Use of digital self-care solutions for diabetes long-term management: a scoping review protocolJorge César Correia, Cosette Fakih El Khoury, Dayana El Chaar, et al.
European Heart Journal|February 10, 2011
Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesityAlessandra Quercioli, Zoltan Pataky, Gabriella Vincenti, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 12, 2016
Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell ProtectionJonas W Brinck, Aurélien Thomas, Estelle Lauer, et al.
Acta Physiologica (Oxford, England)|December 22, 2020
Ether lipids, sphingolipids and toxic 1-deoxyceramides as hallmarks for lean and obese type 2 diabetic patientsJ Thomas Hannich, Ursula Loizides-Mangold, Flore Sinturel, et al.
Pageof 11